Nalaganje...

Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions

The discovery of chromosomal rearrangements involving the anaplastic lymphoma kinase (ALK) gene in non-small cell lung cancer (NSCLC) has stimulated renewed interest in oncogenic fusions as potential therapeutic targets. Recently, genetic alterations in ROS1 and RET were identified in patients with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Gainor, Justin F., Shaw, Alice T.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720641/
https://ncbi.nlm.nih.gov/pubmed/23814043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0095
Oznake: Označite
Brez oznak, prvi označite!